Combination of Vaccine Strain Measles Virus and Nimotuzumab in the Treatment of Laryngeal Cancer
- 1 July 2019
- journal article
- research article
- Published by Anticancer Research USA Inc. in Anticancer Research
- Vol. 39 (7), 3727-3737
- https://doi.org/10.21873/anticanres.13521
Abstract
Background/Aim: This study aims to investigate whether the combination of oncolytic viruses with chemoradiotherapy or other therapies is a promising strategy for cancer treatment. Materials and Methods: The anticancer effects of measles virus (MeV) in combination with nimotuzumab in the treatment of laryngeal cancer were evaluated in vitro and in nude mice inoculated with Hep2 tumors. MTT assay and flow cytometry were used to examine cell death. Results: Laryngeal cancer cells treated with MeV+nimotuzumab combination had a significantly lower survival rate compared to those treated with MeV or nimotuzumab alone (p<0.0001). In an animal model bearing human laryngeal tumor, the treated group had a higher survival rate (60%) compared to a untreated group (20%) (p<0.05), and the survival rate of the group treated with MeV+nimotuzumab combination was higher compared to the groups received single treatment. Conclusion: The MeV+nimotuzumab combination has greater anticancer activities in both laryngeal cancer cells and an animal model.Keywords
This publication has 27 references indexed in Scilit:
- Nimotuzumab Enhances the Radiosensitivity of Cancer Cells In Vitro by Inhibiting Radiation-Induced DNA Damage RepairPLOS ONE, 2013
- Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung AdenocarcinomaCancer Research, 2012
- Attenuated, Oncolytic, but Not Wild-Type Measles Virus Infection Has Pleiotropic Effects on Human Neutrophil FunctionThe Journal of Immunology, 2012
- Expression of Measles Virus Nucleoprotein Induces Apoptosis and Modulates Diverse Functional Proteins in Cultured Mammalian CellsPLOS ONE, 2011
- Rethinking the Head and Neck Cancer PopulationClinical Journal of Oncology Nursing, 2011
- Toxicology Study of Repeat Intracerebral Administration of a Measles Virus Derivative Producing Carcinoembryonic Antigen in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent GliomasHuman Gene Therapy, 2008
- Combination of Measles Virus Virotherapy and Radiation Therapy Has Synergistic Activity in the Treatment of Glioblastoma MultiformeClinical Cancer Research, 2007
- Heat shock proteins as vaccine adjuvants in infections and cancerDrug Discovery Today, 2006
- Oncolytic measles virus targets high CD46 expression on multiple myeloma cellsExperimental Hematology, 2006
- Replication-selective oncolytic viruses in the treatment of cancerCancer Gene Therapy, 2004